Panelists all agree that there needs to be evidence and guidelines for both payers and providers. There are not enough resources to try every drug on every patient. Although it will be costly, there needs to be evidence on putting these drugs together as combinations.
Panelists all agree that there needs to be evidence and guidelines for both payers and providers. There are not enough resources to try every drug on every patient. Although it will be costly, there needs to be evidence on putting these drugs together as combinations. “We have the American ingenuity and the wherewithal that we’ll find better ways to do it, or other drugs that come along that are less expensive in the same category,” said Dr Crawford. “I think we really owe that to men with advance state prostate cancer to make that step and start doing it.” “I think there is a blend here of continuing to do the envelope-pushing combination strategies,” said Dr George. “With cost to the wind, let’s try to cure the disease because that’s going to be the most cost-effective manner of managing these patients in the long-run anyway.”
Dr Shore offers his rebuttal by saying he thinks that a real issue is having patients reimbursed for all of the expensive newly approved agents. He says, by law, if there is a level 2 recommendation by the National Comprehensive Cancer Network the Centers for Medicare & Medicaid Services has to reimburse which is important to the payer population
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
The Joint Commission is launching the Rural Health Clinic Accreditation Program to standardize staff training and patient care practices at rural health clinics nationwide; the American Cancer Society recently launched the largest-ever study of cancer risk and outcomes in Black women; the HHS COVID-19 vaccination campaign saved $732 billion by preventing illness and related costs.
Read More